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Quantification of Optical Coherence Tomography Angiography
in Age and Age-Related Macular Degeneration Using Vessel
Density Analysis
Ehsan Vaghefi, PhDy, Sophie Hill, MDz, Hannah M. Kersten, PhD,
and David Squirrell, FRANZCOz
Purpose: The aim of this study was to determine whether vessel
density (VD) as measured by optical coherence tomography (OCT)
angiography provided insights into retinal and choriocapillaris vascu-
lar changes with aging and intermediate dry age-related macular
degeneration (AMD).
Design: Non-randomized observational study.
Methods: Seventy-five participants were recruited into 3 cohorts: young
healthy group, old healthy, and those at high-risk for exudative AMD.
Raw OCT and OCT angiography data from TOPCON DRI OCT Triton
were exported using Topcon IMAGENET 6.0 software, and 3D datasets
were analysed to determine retinal thickness and VD.
Results: Central macular thickness measurements revealed a trend of
overall retinal thinning with increasing age. VD through the full thickness
of the retina was highest in Early Treatment Diabetic Retinopathy Study
(ETDRS) sector 4 (the inferior macula) in all the cohorts. Mean VD was
significantly higher in the deep capillary plexus than the superficial
capillary plexus in all ETDRS sectors in all cohorts, but there was no
significant difference noted between groups. Choriocapillaris VD was
significantly lower in all ETDRS sectors in the AMD group compared
with the young healthy and the old healthy groups.
Conclusions: Retinal VD maps, derived from the retinal plexi, are not
reliable biomarkers for assessing the aging macular. Our nonproprietary
analysis of the vascular density of the choriocapillaris revealed a signifi-
cant drop off of VD with age and disease, but further work is required to
corroborate this finding. If repeatable, choriocapillaris VD may provide a
noninvasive biomarker of healthy aging and disease.
Key Words: age-related macular degeneration, optical coherence
tomography angiography, retinal blood flow, vessel density
(Asia Pac J Ophthalmol (Phila) 2020;9:137–143)
C urrently we lack a reliable, noninvasive vascular biomarkerto monitor both the “healthy” aging and disease progression
of age-related macular degeneration (AMD). Optical coherence
tomography angiography (OCT-A) represents a novel, noninva-
sive, dye-less retinal vascular imaging technique that can be
rapidly acquired during a clinical consultation. OCT-A is a
progression of OCT, using repeated B-scans to detect motion
contrast.1 Based on the assumption that this represents the move-
ment of erythrocytes travelling through the retinal blood vessels,
the retinal vasculature can therefore be visualized.2 Previous
studies have shown the value of this imaging technique in the
evaluation of glaucoma, diabetic retinopathy (DR), retinal vein
occlusions, and AMD3.
The laminar structure of the retina lends itself to segmenta-
tion analysis. Histologically, the retina has four retinal capillary
plexuses, within the macular only 3 of these are considered: the
superficial, deep, and intermediate capillary plexuses.4,5 When
the macular vasculature is imaged using OCT-A, the vascular
layers are segmented automatically by the software. This results
in the merging of the intermediate with the deep capillary plexus.3
The regions of interest identified on the OCT-A therefore include
the superficial capillary plexus (SCP) and the deep capillary
plexus (DCP).3 The SCP consists of the vasculature within the
retinal nerve fibre layer and ganglion cell layer. The DCP
represents the vascular plexuses present at two locations: these
plexuses are at the border of the inner nuclear layer and the outer
plexiform layer, and the border of the inner plexiform layer and
inner nuclear layer.6
OCT-A images can be subjectively appraised for the pres-
ence of disease or post processed to produce quantitative data that
can be evaluated objectively. A number of studies7,8 have used
perfusion indices such as vessel density (VD) and flow index9 as a
method of quantitatively analysing OCT-A images. VD is defined
as the “percentage area occupied by vessels in the segmented
area.”9 Flow index is defined as “the average decorrelation values
in the segmented area.”9 It has been proposed that these indices
could be of value in monitoring disease progression in AMD and
DR.7,10,11 When measuring VD, both vessel length and diameter
need to be considered. Poor perfusion can also result in vessel
dilation; therefore, VD may not give complete information about
the retinal vascular status.12
There are a wide range of OCT-A devices available, each
using a variety of algorithms to capture retinal images. These
include OCT-based optical microangiography; split-spectrum
amplitude decorrelation angiography; OCT angiography ratio
analysis; speckle variance; phase variance; and correlation map-
ping.13 Specific OCT-A models such as the AngioVue (Optovue,
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ORIGINAL STUDY
Inc., Fremont, CA) have inbuilt software for perfusion indices
calculation.14 However, the majority of studies have applied post
image analysis in a variety of methods after the images are
exported from the OCT-A instrument.2
This heterogeneity in the image capture and analysis
means that data calculated using different algorithms are not
directly comparable, due to systemic difference and poor agree-
ment.2 Therefore, external normative databases are unreliable
and longitudinal monitoring of disease using VD requires scans to
be performed using the same instrument, scan location, and
algorithm.2
The aims of this study are to compare the macular VD values
for young healthy (YH), old healthy (OH), and patients with
intermediate dry AMD at high risk of progression to exudative
AMD, and to determine whether these perfusion indices could
usefully serve as a biomarker for both “healthy” aging and the
identification of disease risk.
MATERIALS AND METHODS
Seventy-five participants were recruited through Auckland
Optometry Clinic and Milford Eye Clinic, Auckland, New Zea-
land. All participants provided written informed consent before
imaging. Ethics approval (#018241) from the University of Auck-
land Human Participants Ethics Committee was obtained for this
study. This research adhered to the tenets of the Declaration
of Helsinki.
Participants were divided into 3 groups: YH group, OH
group and the high-risk intermediate AMD group. Twenty
participants were recruited into the YH group, 21 were
recruited into the OH group, and 34 recruited into the AMD
group. A comprehensive eye examination was conducted on
each participant before the OCT and OCT-A scans to determine
high contrast best corrected visual acuity and the ocular health
status of the fundus. Patients with any posterior eye disease that
could potentially affect the choroidal or retinal vasculature
including, but not limited to glaucoma, polypoidal choroidal
vasculopathy, DR, hypertensive retinopathy, and high myopia
(6D), were excluded from the study. Patients with any history
of neurological disorders were also excluded. The YH group
consisted entirely of individuals between the ages of 20 and 26 a
best corrected visual acuity of 6/9 in the eye under test. The
“OH” group consisted of individuals over the age of 55 years and
who had a best corrected visual acuity of 6/9 in the eye
under test. The “AMD group” consisted entirely of patients with
high risk intermediate dry AMD. This being diagnosed if the
individual had at least two of the following risk factors; reticular
pseudodrusen, established neovascular AMD in the fellow eye,
confluent soft drusen with accompanying changes within the
retinal pigment epithelium. To ensure that all patients in the
“AMD cohort” could maintain fixation during OCT-A imaging,
only those patients with a best-corrected visual acuity of 6/15 or
better were enrolled. The mean age of the participants in the YH
group, OH, and AMD participants were 23 3, 65 10, and
75 8 years, respectively. Only 1 eye of each patient was used for
the analysis, and if the patient had both eyes scanned, the OCT-A
scan that had the better quality (assessed subjectively by the
clinical grader) of the two was used. Mean best-corrected
visual acuity for the YH, OH, and AMD group were 6/6, 6/9,
and 6/12, respectively.
The ocular health of all participants was assessed at
Auckland Optometry Clinic, by a registered optometrist, before
enrollment in the study. The macular status of patients enrolled
into the AMD group was assessed separately by an experienced
retinal specialist (DS).
Data Collection Protocol
Participants were dilated with 1.0% tropicamide if the pupils
were deemed to be too small for adequate OCT scans. Intraocular
pressures were measured before and after dilation by iCare
tonometry. OCT/OCT-A scans, fundus photography, and clinical
measurements were all performed at the University of Auckland
Optometry Clinic, in a single session.
SS-OCT-A Device and Scanning Protocol
The swept source OCT-A device (Topcon DRI OCT
Triton, Topcon Corporation, Japan) was used to obtain the
OCT and OCT-A scans. A macular line and 3 3mm2 OCT,
and 3 3mm2 OCT-A scan were performed on each participant.
All scans were centered on the fovea, and retinal layers
were identified using the IMAGENET 6.0 automated layer
detection tool so that the SCPs and DCPs could be evaluated.
The quality of the generated layers was checked manually. Scan
quality was evaluated at the time of acquisition, and repeated
if required.
Quantitative Analysis of OCT-A Images
Raw OCT and OCT-A data were exported using Topcon
IMAGENET 6.0 software. As OCT-A images are only qualitative,
we chose to normalize the OCT-A datasets, before further analy-
sis. These datasets were then correlated with VD in each retinal
sector. OCT-A 3D datasets were analyzed in 3 different ways
(outlined below), to investigate the retinal and choroidal thickness
and VD. To ensure that any differences observed between cohorts
were real, we repeatedly performed a VD analysis on a single
individual (repeated 15 times over a period of 2 hours). The
proprietary Triton optical coherence tomography angiography
(OCTA) software (IMAGENET6) was used to generate vessel
densities for each scan, using the same Early Treatment Diabetic
Retinopathy Study (ETDRS) regions as dictated by our study
protocol. Using these data the intraclass correlation and concor-
dance correlation coefficient were calculated. The mean (SD) of
the absolute difference between each test was also derived.
ETDRS-specific
The 9 ETDRS sectors were computationally generated and
centered manually by the clinical examiner, on the fovea (using
enface OCT-A) for each participant. In some instances, the
macular region was not in the center of the enface 3 3mm2
OCT-A scan. Hence, after manual adjustment of the ETDRS
central positioning on the fovea, the outer ETDRS regions (ie, 6–
9) could have been positioned outside of the imaging area.
Therefore, in this study in which we were interested in assessing
the role VD may play as a potential biomarker for aging and
disease of the central macular, we only used ETDRS regions 1 to 5
for consistency in our analysis. In this process, the OCT-A signal
is extracted and saved for each ETDRS region, superimposed on
every OCT-A enface layer. In other words, all the 3 3mm2
OCT-A layers through the retinal thickness are combined to create
an OCT-A volume dataset, 920 of them per 3 3mm2 scan, using
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the Topcon DRI OCT. Finally, the ETDRS regions are manually
applied to each of the 920 enface OCT-A images and OCT-A
normalized data per region are extracted (Fig. 1). This method has
been recently published.15 The averaged normalized VD of the
full thickness retina and choriocapillaris of each ETDRS region
was then extracted from every participant for further analysis.
Normalization was performed by converting the raw data to
percentage of VD in all ETDRS regions, throughout the thickness
of the retina.
SCP, DCP, and Choriocapillaris
Using the same ETDRS regions as above, the VD was
extracted from layers 1 and 2 for the SCP calculation, layers 3
and 4 for the DCP, and layer 8 for the choriocapillaris. Averaged
normalized VD from the SCP, DCP, and choriocapillaris was then
extracted for each participant, in the 3 groups.
Retinal and Choroidal Thickness
In addition to OCT-A data, we also recorded the foveal
thickness and subfoveal choroidal thickness from the OCT B-
scans.
Statistical Analysis
MATLAB programming software and custom-written code
was used to import and analyze the data, as detailed above.
Statistical analysis was performed using MATLAB Statistics
Toolbox. Due to unequal sample sizes between the sample groups,
we performed the 2 sample nonparametric Kolmogorov and
Smirnov test, which is one of the most general nonparametric
methods for comparing 2 samples. The Kolmogorov and Smirnov
method assumes that the data in both groups follow Gaussian
distributions. Significant differences between groups were
defined as D <0.565 for the Kolmogorov and Smirnov test.
FIGURE 1. Retinal layers were automatically identified by IMAGENET 6 software (A), the SCP and DCP were then isolated from layers 1 and 2, and 3
and 4, respectively. ETDRS regions 1-9 are superimposed onto the enface OCT-A images and manually adjusted so that sector 1 was centered on the
fovea. In this study we selected sectors 1-5 (B). ETDRS indicates Early Treatment Diabetic Retinopathy Study; DCP, deep capillary plexus; OCT-A,
optical coherence tomography angiography; SCP, superficial capillary plexus.
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RESULTS
Test-retest Variability Assessment
The intraclass correlation factor was found to be 0.993.
The concordance correlation coefficient was found to be 0.989.
The mean of the absolute difference between each test was
3.72 2.57mm.
Mean Age, Central Macular Thickness, and Foveal
Avascular Zone Diameter
Seventy-five participants were included in this study of which
20 were in the YH group (23 3 years old), 21 in the OH group,
(65 10 years old) and 34 in the AMD group (75 8 years old).
OCT data were segmented by IMAGENET 6.0 software, and
the mean central macular thickness measurements for the 3 partici-
pating cohorts was extracted: YH, 217.4 9.28mm; OH,
209.8 6.13mm; AMD, 174.2 20.3mm. Horizontal diameter
of the foveal avascular zone (FAZ) was also measured from each
OCT and mean FAZ measurements were calculated: YH,
672.5 73.4mm; OH, 577.7 98.8mm; AMD, 639 126.2mm.
VD Measurements: Full Retinal Thickness
Table 1 shows the mean VD throughout the full retinal
thickness, for each ETDRS sector. In all groups, the highest
VD was found in sector 4, the inferior macula. Lowest VD in
all groups was in sector 1 the foveal/parafoveal region. A statisti-
cal difference between the VD in Sector 1 was found between all
the groups, with the VD being higher in the AMD cohort
(29.6 19.8) compared with the YH (7.5 6.6) and OH groups
(14.7 9.68). Analysis of the VD of ETDRS sectors 2 to 5,
revealed that there was a statistical difference in the VD between
the AMD group and both the YH and OH groups, but not between
the YH and OH groups.
VD measurements: SCP Segment
Table 2 shows the mean VD of the SCP segment within each
ETDRS sector in each group. Although there was a trend towards
the mean VD derived from the SCP in all ETDRS sectors being
higher in the AMD cohort compared with the 2 healthy cohorts, no
significant difference was found in the VD’s recorded in any of
the 5 ETDRS sectors between the 3 cohorts.
VD measurements: DCP Segment
Table 3 shows the mean VD of the DCP segment within each
ETDRS sector for all groups.
The mean VDwas found to be significantly higher (<0.01) in
the DCP than the SCP in all ETDRS sectors and in all groups.
Although there was a trend toward the mean VD derived from the
DCP in ETDRS sector 1 being higher in the AMD cohort
compared with the 2 “healthy” cohorts, the difference was not
TABLE 1. Mean Vessel Density From Full Retinal Thickness Per ETDRS Sector, for Each Group
ETDRS Sectors Foveal % (1) Superior % (2) Nasal % (3) Inferior % (4) Temporal % (5)
Young healthy
n¼ 20
7.5þ 6.6 18.1þ 7.3 16.0þ 7.0 20.5 8.3 18.2þ 8.1
Old healthy
n¼ 21
14.7þ 9.8 21.1þ 8.3 20.8þ 9.9 21.5.þ 11 21.1þ 9.6
AMD
n¼ 34
29.6þ 19.8 48.5þ 31.4 43.8þ 31.9 47.7þ 27.9 48.6þ 24.8
AMD indicates age-related macular degeneration; ETDRS, Early Treatment Diabetic Retinopathy Study.
TABLE 2. Mean Vessel Density in Superficial Capillary Plexus Defined in Sectors Based on the ETDRS Chart (Foveal, Superior, Nasal, Inferior, and
Temporal)
ETDRS Sectors Foveal % (1) Superior % (2) Nasal % (3) Inferior % (4) Temporal % (5)
Young healthy
n¼ 20
19.8 3.3 25.0 4.7 24.5þ 4.2 27.8þ 4.8 25.5þ 4.8
Old healthy
n¼ 21
21.3 3.9 25.9.þ 3.5 25.7 4.1 26.7.þ 4.9 24.6.þ 5.0
AMD
n¼ 34
25.4 7.9 30.4þ 10.5 30.7þ 11.1 32.5 11.0 32.0þ 8.5
AMD indicates age-related macular degeneration; ETDRS, Early Treatment Diabetic Retinopathy Study.
TABLE 3. Mean Vessel Density in Deep Capillary Plexus Defined in Sectors Based on the ETDRS Chart (Foveal, Superior, Nasal, Inferior, and Temporal)
ETDRS Sectors Foveal % (1) Superior % (2) Nasal % (3) Inferior % (4) Temporal % (5)
Young healthy
n¼ 20
27.0þ 12.9 62.3 23.1 60.0 20.1 64.8 21.5 59.9þ 21.2
Old healthy
n¼ 21
35.9þ 20.3 57.1 19.9 56.3 22.6 56.6 22.1 54.1þ 24.8
AMD
n¼ 34
43.8þ 31.6 55.0þ 44 53.9 41.1 62.0 50.1 55.6þ 40.6
AMD indicates age-related macular degeneration; ETDRS, Early Treatment Diabetic Retinopathy Study.
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statistically significant. There was a trend for the mean VD
derived from the DCP in the remaining ETDRS sectors: 2 to 5,
to be higher in the YH cohort compared with the other 2 cohorts.
This difference was not statistically significant.
VD measurements: Choriocapillaris Segment
Table 4 shows the mean VD of the choriocapillaris segment
within each ETDRS sector for all groups. In contrast to the
measurements recorded in the retinal segments, statistically sig-
nificantly lower mean VDs were recorded in the choriocapillaris
segment layer in the AMD group across all ETDRS sectors
compared with the 2 healthy groups. There was no significant
difference in the VDs measured in each of the ETDRS sectors
between YH and the OH groups.
DISCUSSION
Although a number of changes within the aging macular
have previously been reported, a reliable, noninvasive biomarker
of both “healthy” macular aging and disease risk remains elusive.
Retinal thickness, both at the fovea and extra-foveal regions,
has previously been shown to differ significantly between indi-
viduals with early AMD and age-matched controls with the retina
being thinner in individuals with disease.16 The results of our
study also revealed that there was a trend for the overall retinal
thickness to thin with age, but this difference was not statistically
significant between cohorts. It is also recognized that the choroid
tends to thin with age, with the nasal area being thinnest, and the
subfoveal region being thickest.17 In addition to thinning with
“normal aging,” choroidal thinning has also been demonstrated in
individuals with early AMD compared with age matched con-
trols16,18–20; however, the significance of this observation is
controversial as both the extent and the pattern of thinning is
significant in some20 but not all studies.16,18,19 The histological
evidence regarding choroidal thickness is also contradictory
with some studies showing reduction in late AMD21 and others
showing no change19; moreover, the changes in the vasculature
of the choriocapillaris in early AMD that have been reported
from histological studies19,21 seem to be independent of choroidal
thickness.
Similarly inconclusive observations have been reported with
respect to the width of the FAZ with age. Although some studies
report no difference with age,22,23 others have found that the FAZ
enlarges with increasing age.24,25 Where reported, the foveal
avascular zone at the level of the SCP has been found to be
significantly smaller in >60 years old compared with younger
study groups,14 but the significance of this difference is unknown
and furthermore, no difference was observed when the FAZ at the
level of the DCP was analyzed.14 Recently, a study studying the
FAZ in patients with intermediate nonexudative AMD found no
significant difference in the width of the FAZ between patients
with nonexudative AMD and healthy controls.26 We likewise
found there to be no statically significant difference in the
diameter of the FAZ between any of the 3 cohorts studied.
Where objective measures of macular anatomy have failed,
OCTA may provide an opportunity to develop a reliable, nonin-
vasive vascular biomarker of the aging macular. The proprietary
OCTA software now has a VD function which, in brief uses the
proportion of bright pixels to the proportion of dark pixels to
derive a measure of vascular density. In the first instance we
reviewed the mean VD percentage throughout the full retinal
thickness, for each ETDRS sector. We then used the segmentation
function of the enface OCTA to explore the relationship of the
vessel densities within each of the ETDRS sectors 1 to 5 in each of
the 3 vascular zones of the central macular; (SCP, DCP, chorio-
capillaris) across the 3 cohorts: YH, OH, and AMD. As with any
instrument, OCTA measurements will have a test retest variation,
but currently there is no published literature informing us of the
magnitude of this variability for the Triton OCTA. Thus, to ensure
that differences between groups were “real,” we had to first derive
this statistic and the intraclass correlation factor and the concor-
dance correlation coefficients, 2 such measurements that describe
the accuracy of the test–retest reliability of a machine like OCTA.
In our preliminary study both measured 0.99, a result, which
indicates that the data produced by Triton OCTA is highly
reproducible. The additional finding that the mean of the absolute
difference between each repeat test was small (3.72 2.57um)
indicates that the OCTA is capable of both precisely and accu-
rately measuring VD and thus the differences we record between
groups are indeed “real.”
As one might expect, the VDs derived from the relatively
avascular ETDRS sector 1 were, in the full thickness maps,
significantly reduced compared with the VDs derived from
ETDRS sectors 2 to 5 in the YH, OH, and AMD cohorts.
However, and curiously, the VD recorded in the AMD cohort
was significantly higher than in the 2 “healthy” cohorts, and
although there was a trend for the VDs derived from the YH
cohort to be reduced compared with the OH cohort, this difference
was not significant. Aside the marked difference between the
AMD cohort and the other 2 “healthy” cohorts, no other clinically
relevant or statistically significant patterns were noted in the VDs
derived from the full thickness retinal maps.
Overall, and when the retinal vascular complexes were
analyzed as separate segments, the highest vessel densities were
found in sectors 2 and 4; the superior and inferior macula. Again
the VDs derived from ETDRS sector 1 were greater in the AMD
TABLE 4. Mean Vessel Density in the Choriocapillaris, Based on the ETDRS Chart (Foveal, Superior, Nasal, Inferior, and Temporal)
ETDRS Sectors Foveal Ratio (1) Superior Ratio (2) Nasal Ratio (3) Inferior Ratio (4) Temporal Ratio (5)
Young healthy
n¼ 20
97þ 10.5 86.2þ 10.7 90.8þ 11 103.8þ 9.8 103þ 11.3
Old healthy
n¼ 21
97þ 4.5 85.5þ 8.5 83.9þ 9.5 86.3þ 10.5 80.1þ 12.8
AMD
n¼ 34
71.4þ 24.3 68.1þ 23.8 69.7þ 24.4 68.4þ 22.7 73.1þ 19.4
AMD indicates age-related macular degeneration; ETDRS, Early Treatment Diabetic Retinopathy Study.
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cohort compared with the 2 “healthy” cohorts. Although there was
a trend for the VDs derived from the OH cohort to be lower
compared with the YH cohort, this difference was not significant.
The spatial variation in VDs that we observed; ie, a higher mean
VD in the inferior and superior ETDRS sectors and a lower mean
VD in the temporal and nasal sectors, in both the deep and
superficial capillary plexi, is consistent with published data from
previous studies.14,22,23 Like others,14,27 we also observed that in
all ETDRS sectors and in all 3 study groups, the mean VD derived
from the DCP was significantly higher than that derived from
the SCP.
The association between age and VD remains unclear, with
reports of statistically significant lower mean VD in SCP, DCP,
and full thickness of retina in each ETDRS sector in patients >60
years old compared with younger cohorts14; however, others who
have studied this have found no such correlation.22 On the whole,
our results do not further our understanding of VD changes with
age, being similarly inconclusive. On the basis of these data, one
has to conclude that without further work, VDs derived from the
retinal segments are not a reliable biomarker for “healthy” aging.
One consistent feature of the VDs derived from the retinal
segments in the present study was the finding that the VDs
recorded from ETDRS sector 1, and indeed in many other ETDRS
sectors in the AMD cohort, were as a group consistently higher
than those obtained from the “healthy” cohorts. One possible
explanation for this surprising result is the technical challenges of
obtaining high quality OCT-A scans from individuals with even
modest visual impairment as accurate central fixation during the
OCT-A capture can be challenging. Many of the patients in our
AMD cohort struggled to maintain fixation during the image
acquisition stage, despite the majority recording a Snellen acuity
of 6/12. Increased acquisition time and the resultant compromise
in image quality means there is a higher likelihood of projection
and banding artefacts.28 Motion artefacts can also lead to the
duplication of inner retinal vascular structures.29 As VD is derived
from the percentage of the area occupied by bright pixels in a
segmented area, errors such as vessel duplication and banding
artefacts could be incorrectly interpreted during computational
analysis as increased VD within the image. Such an error would
be magnified in ETDRS sector 1 where the effects of these
banding and motion artefacts would be more pronounced in what
should be avascular tissue.
Although the proprietary OCTA software to assess VD is
designed tomeasure the inner retinal plexi, a vascular bedwhich has
a very different architecture to the choriocapillaris,30 we were
curious to know whether the principle of VD analysis could be
used to assess the vascularity of the choriocapillaris. We therefore
extracted the raw data, and then used a manual analysis method
previously published in the literature,15 to assess the “vascular
density” of the choriocapillaris segment. Even allowing for the
influence of banding and motion artefacts, issues which should
increase VDmeasurements, we observed a significant reduction in
the VD in both the AMD and OH cohorts compared with the YH
cohort with the reduction in VD being most marked in the AMD
cohort (Table 4). This contrasts sharply with the data derived from
the retinal plexi, which broadly showed no difference between
groups. Although interesting, one has to interpret these findings
with caution because, to the best of our knowledge, VDanalysis has
not previously been used to assess the choriocapillaris. Currently, it
is therefore not possible to corroborate these findings. However, a
global reduction in choriocapillaris density, associated with drusen
on OCT-A in dry AMD, has been demonstrated previously.6 It is
also recognized that the inner choroid and the choriocapillaris
disproportionally thin with age and disease.31 It is feasible that a
thinning choriocapillaris would be less vascular and other groups
have hypothesized that choroidal perfusion changes on the OCT-A
may predict disease progression.6 Debate about whether this is
related to actual flow impairment6 or projection artefact “masking”
the choriocapilaris29,32 due to large drusen or pigment epithelial
detachments attenuating theOCT-A signal is still ongoing.Without
further corroborative work, the importance of our finding that there
is a progressive reduction in choriocapillaris VD in age and disease
is difficult to assess. Furthermore, because ourOHgroup andAMD
cohorts are not age-matched, it is not possible to comment on
whether any observed reduction is simply an aging phenomenon or
a marker of disease. Nevertheless, if reproducible, such a measure
has the potential to provide a noninvasive biomarker of both
“healthy” macular aging and disease risk. Further limitations of
this study include a small sample size, which might reduce the
generalizability of our findings and the interpretation of the statis-
tical significance of our data. Furthermore, the Kolmogorov and
Smirnov statistical test assumes the Gaussian distribution of the
tested data.
CONCLUSIONS
OCT-A mean retinal VD results for normal subjects are in
line with the existing literature. Challenges of image acquisition
and the significant influence of image artefact on post-acquisition
analysis of patients with mild visual loss due to intermediate
AMD further limits the value of VD measurements in this patient
group. We believe that our data suggest that traditional measures
of VD, derived from the retinal plexi, are therefore unreliable
biomarkers for both “healthy” aging and quantifying risk of
developing AMD. In contrast, our nonproprietary analysis of
the vascular density of the choriocapillaris revealed a significant
drop off of VD with age and disease. Although further work is
required to corroborate this finding, if repeatable, choriocapillaris
VD may provide a noninvasive biomarker of healthy aging
and disease.
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